目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022 - 2027
Exhibit 14: Chart on Global - Market size and forecast 2022 - 2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022 - 2027 ($ million)
Exhibit 16: Chart on Global Market: Year - over - year growth 2022 - 2027 (%)
Exhibit 17: Data Table on Global Market: Year - over - year growth 2022 - 2027 (%)

4 Historic Market Size
4.1 Global central nervous system (CNS) stimulant drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global central nervous system (CNS) stimulant drugs market 2017 - 2021 ($ million)
4.2 Distribution channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022 - 2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022 - 2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospitals - Market size and forecast 2022 - 2027
Exhibit 34: Chart on Hospitals - Market size and forecast 2022 - 2027 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2022 - 2027 ($ million)
Exhibit 36: Chart on Hospitals - Year - over - year growth 2022 - 2027 (%)
Exhibit 37: Data Table on Hospitals - Year - over - year growth 2022 - 2027 (%)
6.4 Others - Market size and forecast 2022 - 2027
Exhibit 38: Chart on Others - Market size and forecast 2022 - 2027 ($ million)
Exhibit 39: Data Table on Others - Market size and forecast 2022 - 2027 ($ million)
Exhibit 40: Chart on Others - Year - over - year growth 2022 - 2027 (%)
Exhibit 41: Data Table on Others - Year - over - year growth 2022 - 2027 (%)
6.5 Market opportunity by Distribution Channel
Exhibit 42: Market opportunity by Distribution Channel ($ million)
Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Application
7.1 Market segments
Exhibit 44: Chart on Application - Market share 2022 - 2027 (%)
Exhibit 45: Data Table on Application - Market share 2022 - 2027 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Attention - deficit hyperactivity disorder - Market size and forecast 2022 - 2027
Exhibit 48: Chart on Attention - deficit hyperactivity disorder - Market size and forecast 2022 - 2027 ($ million)
Exhibit 49: Data Table on Attention - deficit hyperactivity disorder - Market size and forecast 2022 - 2027 ($ million)
Exhibit 50: Chart on Attention - deficit hyperactivity disorder - Year - over - year growth 2022 - 2027 (%)
Exhibit 51: Data Table on Attention - deficit hyperactivity disorder - Year - over - year growth 2022 - 2027 (%)
7.4 Narcolepsy - Market size and forecast 2022 - 2027
Exhibit 52: Chart on Narcolepsy - Market size and forecast 2022 - 2027 ($ million)
Exhibit 53: Data Table on Narcolepsy - Market size and forecast 2022 - 2027 ($ million)
Exhibit 54: Chart on Narcolepsy - Year - over - year growth 2022 - 2027 (%)
Exhibit 55: Data Table on Narcolepsy - Year - over - year growth 2022 - 2027 (%)
7.5 Others - Market size and forecast 2022 - 2027
Exhibit 56: Chart on Others - Market size and forecast 2022 - 2027 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2022 - 2027 ($ million)
Exhibit 58: Chart on Others - Year - over - year growth 2022 - 2027 (%)
Exhibit 59: Data Table on Others - Year - over - year growth 2022 - 2027 (%)
7.6 Market opportunity by Application
Exhibit 60: Market opportunity by Application ($ million)
Exhibit 61: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share by geography 2022 - 2027 (%)
Exhibit 64: Data Table on Market share by geography 2022 - 2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022 - 2027
Exhibit 67: Chart on North America - Market size and forecast 2022 - 2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022 - 2027 ($ million)
Exhibit 69: Chart on North America - Year - over - year growth 2022 - 2027 (%)
Exhibit 70: Data Table on North America - Year - over - year growth 2022 - 2027 (%)
9.4 Europe - Market size and forecast 2022 - 2027
Exhibit 71: Chart on Europe - Market size and forecast 2022 - 2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022 - 2027 ($ million)
Exhibit 73: Chart on Europe - Year - over - year growth 2022 - 2027 (%)
Exhibit 74: Data Table on Europe - Year - over - year growth 2022 - 2027 (%)
9.5 Asia - Market size and forecast 2022 - 2027
Exhibit 75: Chart on Asia - Market size and forecast 2022 - 2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022 - 2027 ($ million)
Exhibit 77: Chart on Asia - Year - over - year growth 2022 - 2027 (%)
Exhibit 78: Data Table on Asia - Year - over - year growth 2022 - 2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022 - 2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022 - 2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022 - 2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year - over - year growth 2022 - 2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year - over - year growth 2022 - 2027 (%)
9.7 US - Market size and forecast 2022 - 2027
Exhibit 83: Chart on US - Market size and forecast 2022 - 2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022 - 2027 ($ million)
Exhibit 85: Chart on US - Year - over - year growth 2022 - 2027 (%)
Exhibit 86: Data Table on US - Year - over - year growth 2022 - 2027 (%)
9.8 Canada - Market size and forecast 2022 - 2027
Exhibit 87: Chart on Canada - Market size and forecast 2022 - 2027 ($ million)
Exhibit 88: Data Table on Canada - Market size and forecast 2022 - 2027 ($ million)
Exhibit 89: Chart on Canada - Year - over - year growth 2022 - 2027 (%)
Exhibit 90: Data Table on Canada - Year - over - year growth 2022 - 2027 (%)
9.9 UK - Market size and forecast 2022 - 2027
Exhibit 91: Chart on UK - Market size and forecast 2022 - 2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022 - 2027 ($ million)
Exhibit 93: Chart on UK - Year - over - year growth 2022 - 2027 (%)
Exhibit 94: Data Table on UK - Year - over - year growth 2022 - 2027 (%)
9.10 Germany - Market size and forecast 2022 - 2027
Exhibit 95: Chart on Germany - Market size and forecast 2022 - 2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022 - 2027 ($ million)
Exhibit 97: Chart on Germany - Year - over - year growth 2022 - 2027 (%)
Exhibit 98: Data Table on Germany - Year - over - year growth 2022 - 2027 (%)
9.11 China - Market size and forecast 2022 - 2027
Exhibit 99: Chart on China - Market size and forecast 2022 - 2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022 - 2027 ($ million)
Exhibit 101: Chart on China - Year - over - year growth 2022 - 2027 (%)
Exhibit 102: Data Table on China - Year - over - year growth 2022 - 2027 (%)
9.12 Market opportunity by geography
Exhibit 103: Market opportunity by geography ($ million)
Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Azurity Pharmaceuticals Inc.
Exhibit 111: Azurity Pharmaceuticals Inc. - Overview
Exhibit 112: Azurity Pharmaceuticals Inc. - Product / Service
Exhibit 113: Azurity Pharmaceuticals Inc. - Key offerings
12.4 Elite Pharmaceuticals Inc.
Exhibit 114: Elite Pharmaceuticals Inc. - Overview
Exhibit 115: Elite Pharmaceuticals Inc. - Business segments
Exhibit 116: Elite Pharmaceuticals Inc. - Key offerings
Exhibit 117: Elite Pharmaceuticals Inc. - Segment focus
12.5 Hisamitsu Pharmaceutical Co. Inc.
Exhibit 118: Hisamitsu Pharmaceutical Co. Inc. - Overview
Exhibit 119: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Exhibit 120: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
12.6 Ironshore
Exhibit 121: Ironshore - Overview
Exhibit 122: Ironshore - Product / Service
Exhibit 123: Ironshore - Key offerings
12.7 Jazz Pharmaceuticals Plc
Exhibit 124: Jazz Pharmaceuticals Plc - Overview
Exhibit 125: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 126: Jazz Pharmaceuticals Plc - Key news
Exhibit 127: Jazz Pharmaceuticals Plc - Key offerings
12.8 KemPharm Inc.
Exhibit 128: KemPharm Inc. - Overview
Exhibit 129: KemPharm Inc. - Product / Service
Exhibit 130: KemPharm Inc. - Key offerings
12.9 Merck and Co. Inc.
Exhibit 131: Merck and Co. Inc. - Overview
Exhibit 132: Merck and Co. Inc. - Business segments
Exhibit 133: Merck and Co. Inc. - Key news
Exhibit 134: Merck and Co. Inc. - Key offerings
Exhibit 135: Merck and Co. Inc. - Segment focus
12.10 Novartis AG
Exhibit 136: Novartis AG - Overview
Exhibit 137: Novartis AG - Business segments
Exhibit 138: Novartis AG - Key offerings
Exhibit 139: Novartis AG - Segment focus
12.11 Pfizer Inc.
Exhibit 140: Pfizer Inc. - Overview
Exhibit 141: Pfizer Inc. - Product / Service
Exhibit 142: Pfizer Inc. - Key news
Exhibit 143: Pfizer Inc. - Key offerings
12.12 Purdue Pharma LP
Exhibit 144: Purdue Pharma LP - Overview
Exhibit 145: Purdue Pharma LP - Product / Service
Exhibit 146: Purdue Pharma LP - Key offerings
12.13 Sanofi SA
Exhibit 147: Sanofi SA - Overview
Exhibit 148: Sanofi SA - Business segments
Exhibit 149: Sanofi SA - Key news
Exhibit 150: Sanofi SA - Key offerings
Exhibit 151: Sanofi SA - Segment focus
12.14 Takeda Pharmaceutical Co. Ltd.
Exhibit 152: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 153: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 154: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 155: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.15 Teva Pharmaceutical Industries Ltd.
Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 Tris Pharma Inc.
Exhibit 161: Tris Pharma Inc. - Overview
Exhibit 162: Tris Pharma Inc. - Product / Service
Exhibit 163: Tris Pharma Inc. - Key offerings
12.17 Viatris Inc.
Exhibit 164: Viatris Inc. - Overview
Exhibit 165: Viatris Inc. - Business segments
Exhibit 166: Viatris Inc. - Key offerings
Exhibit 167: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022 - 2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022 - 2027 ($ million)
Exhibits16: Chart on Global Market: Year - over - year growth 2022 - 2027 (%)
Exhibits17: Data Table on Global Market: Year - over - year growth 2022 - 2027 (%)
Exhibits18: Historic Market Size - Data Table on Global central nervous system (CNS) stimulant drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022 - 2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022 - 2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospitals - Market size and forecast 2022 - 2027 ($ million)
Exhibits35: Data Table on Hospitals - Market size and forecast 2022 - 2027 ($ million)
Exhibits36: Chart on Hospitals - Year - over - year growth 2022 - 2027 (%)
Exhibits37: Data Table on Hospitals - Year - over - year growth 2022 - 2027 (%)
Exhibits38: Chart on Others - Market size and forecast 2022 - 2027 ($ million)
Exhibits39: Data Table on Others - Market size and forecast 2022 - 2027 ($ million)
Exhibits40: Chart on Others - Year - over - year growth 2022 - 2027 (%)
Exhibits41: Data Table on Others - Year - over - year growth 2022 - 2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits44: Chart on Application - Market share 2022 - 2027 (%)
Exhibits45: Data Table on Application - Market share 2022 - 2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Attention - deficit hyperactivity disorder - Market size and forecast 2022 - 2027 ($ million)
Exhibits49: Data Table on Attention - deficit hyperactivity disorder - Market size and forecast 2022 - 2027 ($ million)
Exhibits50: Chart on Attention - deficit hyperactivity disorder - Year - over - year growth 2022 - 2027 (%)
Exhibits51: Data Table on Attention - deficit hyperactivity disorder - Year - over - year growth 2022 - 2027 (%)
Exhibits52: Chart on Narcolepsy - Market size and forecast 2022 - 2027 ($ million)
Exhibits53: Data Table on Narcolepsy - Market size and forecast 2022 - 2027 ($ million)
Exhibits54: Chart on Narcolepsy - Year - over - year growth 2022 - 2027 (%)
Exhibits55: Data Table on Narcolepsy - Year - over - year growth 2022 - 2027 (%)
Exhibits56: Chart on Others - Market size and forecast 2022 - 2027 ($ million)
Exhibits57: Data Table on Others - Market size and forecast 2022 - 2027 ($ million)
Exhibits58: Chart on Others - Year - over - year growth 2022 - 2027 (%)
Exhibits59: Data Table on Others - Year - over - year growth 2022 - 2027 (%)
Exhibits60: Market opportunity by Application ($ million)
Exhibits61: Data Table on Market opportunity by Application ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2022 - 2027 (%)
Exhibits64: Data Table on Market share by geography 2022 - 2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022 - 2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022 - 2027 ($ million)
Exhibits69: Chart on North America - Year - over - year growth 2022 - 2027 (%)
Exhibits70: Data Table on North America - Year - over - year growth 2022 - 2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022 - 2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022 - 2027 ($ million)
Exhibits73: Chart on Europe - Year - over - year growth 2022 - 2027 (%)
Exhibits74: Data Table on Europe - Year - over - year growth 2022 - 2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022 - 2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022 - 2027 ($ million)
Exhibits77: Chart on Asia - Year - over - year growth 2022 - 2027 (%)
Exhibits78: Data Table on Asia - Year - over - year growth 2022 - 2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022 - 2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022 - 2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year - over - year growth 2022 - 2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year - over - year growth 2022 - 2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022 - 2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022 - 2027 ($ million)
Exhibits85: Chart on US - Year - over - year growth 2022 - 2027 (%)
Exhibits86: Data Table on US - Year - over - year growth 2022 - 2027 (%)
Exhibits87: Chart on Canada - Market size and forecast 2022 - 2027 ($ million)
Exhibits88: Data Table on Canada - Market size and forecast 2022 - 2027 ($ million)
Exhibits89: Chart on Canada - Year - over - year growth 2022 - 2027 (%)
Exhibits90: Data Table on Canada - Year - over - year growth 2022 - 2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022 - 2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022 - 2027 ($ million)
Exhibits93: Chart on UK - Year - over - year growth 2022 - 2027 (%)
Exhibits94: Data Table on UK - Year - over - year growth 2022 - 2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022 - 2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022 - 2027 ($ million)
Exhibits97: Chart on Germany - Year - over - year growth 2022 - 2027 (%)
Exhibits98: Data Table on Germany - Year - over - year growth 2022 - 2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022 - 2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022 - 2027 ($ million)
Exhibits101: Chart on China - Year - over - year growth 2022 - 2027 (%)
Exhibits102: Data Table on China - Year - over - year growth 2022 - 2027 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Azurity Pharmaceuticals Inc. - Overview
Exhibits112: Azurity Pharmaceuticals Inc. - Product / Service
Exhibits113: Azurity Pharmaceuticals Inc. - Key offerings
Exhibits114: Elite Pharmaceuticals Inc. - Overview
Exhibits115: Elite Pharmaceuticals Inc. - Business segments
Exhibits116: Elite Pharmaceuticals Inc. - Key offerings
Exhibits117: Elite Pharmaceuticals Inc. - Segment focus
Exhibits118: Hisamitsu Pharmaceutical Co. Inc. - Overview
Exhibits119: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Exhibits120: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
Exhibits121: Ironshore - Overview
Exhibits122: Ironshore - Product / Service
Exhibits123: Ironshore - Key offerings
Exhibits124: Jazz Pharmaceuticals Plc - Overview
Exhibits125: Jazz Pharmaceuticals Plc - Product / Service
Exhibits126: Jazz Pharmaceuticals Plc - Key news
Exhibits127: Jazz Pharmaceuticals Plc - Key offerings
Exhibits128: KemPharm Inc. - Overview
Exhibits129: KemPharm Inc. - Product / Service
Exhibits130: KemPharm Inc. - Key offerings
Exhibits131: Merck and Co. Inc. - Overview
Exhibits132: Merck and Co. Inc. - Business segments
Exhibits133: Merck and Co. Inc. - Key news
Exhibits134: Merck and Co. Inc. - Key offerings
Exhibits135: Merck and Co. Inc. - Segment focus
Exhibits136: Novartis AG - Overview
Exhibits137: Novartis AG - Business segments
Exhibits138: Novartis AG - Key offerings
Exhibits139: Novartis AG - Segment focus
Exhibits140: Pfizer Inc. - Overview
Exhibits141: Pfizer Inc. - Product / Service
Exhibits142: Pfizer Inc. - Key news
Exhibits143: Pfizer Inc. - Key offerings
Exhibits144: Purdue Pharma LP - Overview
Exhibits145: Purdue Pharma LP - Product / Service
Exhibits146: Purdue Pharma LP - Key offerings
Exhibits147: Sanofi SA - Overview
Exhibits148: Sanofi SA - Business segments
Exhibits149: Sanofi SA - Key news
Exhibits150: Sanofi SA - Key offerings
Exhibits151: Sanofi SA - Segment focus
Exhibits152: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits153: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits154: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits155: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits156: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits157: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits158: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits159: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits161: Tris Pharma Inc. - Overview
Exhibits162: Tris Pharma Inc. - Product / Service
Exhibits163: Tris Pharma Inc. - Key offerings
Exhibits164: Viatris Inc. - Overview
Exhibits165: Viatris Inc. - Business segments
Exhibits166: Viatris Inc. - Key offerings
Exhibits167: Viatris Inc. - Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations